Cellular Entry of Clostridium perfringens Iota-Toxin and Clostridium botulinum C2 Toxin

被引:25
|
作者
Takehara, Masaya [1 ]
Takagishi, Teruhisa [1 ]
Seike, Soshi [2 ]
Oda, Masataka [3 ]
Sakaguchi, Yoshihiko [4 ]
Hisatsune, Junzo [5 ]
Ochi, Sadayuki [6 ]
Kobayashi, Keiko [1 ]
Nagahama, Masahiro [1 ]
机构
[1] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 7708514, Japan
[2] Hiroshima Int Univ, Fac Pharmaceut Sci, Lab Mol Microbiol Sci, Kure, Hiroshima 7370112, Japan
[3] Kyoto Pharmaceut Univ, Dept Microbiol & Infect Control Sci, Kyoto 6078414, Japan
[4] Kitasato Univ, Dept Microbiol, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan
[5] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Bacteriol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan
[6] Yokohama Univ Pharm, Fac Pharm, Totsuka Ku, 601 Matano Cho, Yokohama, Kanagawa 2450066, Japan
来源
TOXINS | 2017年 / 9卷 / 08期
关键词
clostridial binary toxin; iota-toxin; C2; toxin; cellular internalization; PLASMA-MEMBRANE REPAIR; ARGININE ADP-RIBOSYLATION; BINARY TOXINS; INTRACELLULAR TRAFFICKING; ENZYMATIC COMPONENTS; BIOLOGICAL-ACTIVITY; BINDING-COMPONENT; MAMMALIAN-CELLS; LIPID RAFTS; VERO CELLS;
D O I
10.3390/toxins9080247
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Clostridium perfringens iota-toxin and Clostridium botulinum C2 toxin are composed of two non-linked proteins, one being the enzymatic component and the other being the binding/translocation component. These latter components recognize specific receptors and oligomerize in plasma membrane lipid-rafts, mediating the uptake of the enzymatic component into the cytosol. Enzymatic components induce actin cytoskeleton disorganization through the ADP-ribosylation of actin and are responsible for cell rounding and death. This review focuses upon the recent advances in cellular internalization of clostridial binary toxins.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Retargeting the Clostridium botulinum C2 toxin to the neuronal cytosol
    Benjamin J. Pavlik
    Elizabeth J. Hruska
    Kevin E. Van Cott
    Paul H. Blum
    Scientific Reports, 6
  • [32] Uptake of Clostridium perfringens iota toxin into eukaryotic cells
    Blöcker, D
    Behlke, J
    Aktories, K
    Barth, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R5 - R5
  • [33] Cellular Uptake of Clostridium botulinum C2 Toxin Requires Acid Sphingomyelinase Activity
    Nagahama, Masahiro
    Takehara, Masaya
    Takagishi, Teruhisa
    Seike, Soshi
    Miyamoto, Kazuaki
    Kobayashi, Keiko
    INFECTION AND IMMUNITY, 2017, 85 (04)
  • [34] Crystal structure and site-directed mutagenesis of enzymatic components from Clostridium perfringens iota-toxin
    Tsuge, H
    Nagahama, M
    Nishimura, H
    Hisatsune, J
    Sakaguch, Y
    Itogawa, Y
    Katunuma, N
    Sakurai, J
    JOURNAL OF MOLECULAR BIOLOGY, 2003, 325 (03) : 471 - 483
  • [35] THE DEMONSTRATION OF A TOXIN RESEMBLING CLOSTRIDIUM-PERFRINGENS IOTA TOXIN IN RABBITS WITH ENTEROTOXAEMIA
    FERNIE, DS
    EATON, P
    FEMS MICROBIOLOGY LETTERS, 1980, 8 (01) : 33 - 35
  • [36] CLOSTRIDIUM-PERFRINGENS IOTA TOXIN - SYNERGISM BETWEEN 2 PROTEINS
    STILES, BG
    WILKINS, TD
    TOXICON, 1986, 24 (08) : 767 - 773
  • [37] A PCR approach to determine the distribution of toxin genes in closely related Clostridium species:: Clostridium botulinum type C and D neurotoxins and C2 toxin, and Clostridium novyi α toxin
    Heffron, Ann
    Poxton, Ian R.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (02) : 196 - 201
  • [38] Structure and action of the binary C2 toxin from Clostridium botulinum
    Schleberger, Christian
    Hochmann, Henrike
    Barth, Holger
    Aktories, Klaus
    Schulz, Georg E.
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 364 (04) : 705 - 715
  • [39] The actin-ADP-ribosylating Clostridium botulinum C2 toxin
    Aktories, K
    Barth, H
    ANAEROBE, 2004, 10 (02) : 101 - 105
  • [40] Role of oligomerization, pore formation and unfolding in cellular action of Clostridium botulinum C2 toxin
    Wilde, C
    Blöcker, D
    Aktories, K
    Barth, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R5 - R5